LIVE QUOTE |
Quotes delayed 15+ min. |
- Wave of Debt Payments Facing US Government
- US Job Losses to Bottom out Next Quarter: NABE
- Little Sign of Inflation on the Horizon: IMF
- Kraft Weighs Higher Cadbury Bid as Rivals Circle
- MBS Program Should be Extended: Fed's Bullard
- JPMorgan's Dimon Could Succeed Geithner: Report
- Wall Street Finds Profits by Reducing Mortgages
- Microsoft, News Corp Weigh Online News Pact
- Senate Democrats at Odds Over Health Care Bill
- CNBC VIDEO: Warren Buffett & Bill Gates 'Walk & Talk' at Columbia University
- U.S. Stocks Slip, Dollar Rises
- How Stock Investors Can Play Holiday Travel
- Time Lapse World Series Is A Great Play
- Hirschhorn: Greed...or Fear
- My Top 10 Tech Toys for the Holidays
- iPhone a Better Gaming Platform Than Android?
- May Day For Dendreon
- 100% Mortgage Financing From USDA
- Ahead of the Bell: Met-Pro upgrade at Brean Murray
- Schumer and Hutchison argue over health care bill
- Iran says shift to euro netted $5B gain
- Aon to change its NYSE ticker symbol to 'AON'
- Ahead of the Bell: Analyst upgrades Eclipsys
- CDC Software 3Q profit rises on lower costs
- 51job CFO Peter Lui resigns for personal reasons
- Malaysian carmaker Proton posts quarterly profit
- Hong Kong bans ex-CLSA banker from finance jobs
NEW YORK - Walgreen Co. made an offer late Friday to buy Longs Drug Stores Corp. for $2.8 billion, hoping to unseat a rival offer from CVS Caremark Corp. that Longs had already accepted.
Deerfield, Ill.-based Walgreen said it would pay $75 a share in cash to buy Walnut Creek, Calif.-based Longs, besting CVS's price of $71.50 per share, also in cash, which was equivalent to about $2.7 billion. Either deal would also include the assumption of about $200 million in debt.
Longs shares rose 4 percent to $74.50 in after-hours trading.
Walgreen CEO Jeffrey Rein said in a letter to Longs' board of directors that the company would prefer to negotiate with Longs directly but also was prepared to take the offer directly to the company's shareholders.
Rein also noted in the letter, which Walgreen disclosed in a press release late Friday, that Walgreen had expressed an interest in acquiring Longs earlier for $70 a share but never received due diligence materials from the company.
Longs has faced dissent from some shareholders over the value of the CVS deal.
Earlier Friday, one of the largest shareholders in Longs said it opposed the deal with CVS and had identified four other potential buyers for the drug store chain.
Pershing Square Capital Management, which owns about 3 million shares — a 9.2 percent stake — of Longs, has previously said that CVS's bid didn't adequately value Longs' real estate holdings.
Two other major shareholders, Advisory Research and CtW Investment Group, have also publicly questioned the CVS deal.
Speaking in a television interview Friday before the Walgreen announcement, CVS Chief Executive Tom Ryan said the company does not intend to raise its bid.
"We think we are paying a full and fair price," he said. "We're not moving. We're done."
A spokesman for CVS didn't immediately return a call late Friday seeking comment, and a spokesman for Longs wasn't available for comment.
Walgreen, the nation's largest drugstore chain by sales, has 6,356 stores nationwide. The company has said its goal is to have 7,000 stores by 2010.
Longs has more than 500 stores, mostly in California, but also in Hawaii, Nevada and Arizona. The company also owns Rx America, a prescription benefits management program with more than 8 million members.
- Technology can make or break a fortune in the world of alternative energy.
- Warren Buffett and Bill Gates discuss the economy and other subjects with CNBC's Becky Quick.
- Many people are facing the holidays with substantially smaller incomes. Here’s how some are adapting.
- The Victoria's Secret Fashion Show attracts a big TV audience every year, but this year it may take on even more importance.
- Jim Cramer is a proponent of stocks that pay healthy dividends, and here are his top five dividend plays.
- CNBC’s technology reporter Jim Goldman guides you through the best gadgets to buy this holiday season.








